Jason Alger - Jun 3, 2021 Form 4 Insider Report for Health Catalyst, Inc. (HCAT)

Role: Chief Accounting Officer
Signature: /s/ Daniel Orenstein, as Attorney-in-Fact
Stock symbol: HCAT
Transactions as of: Jun 3, 2021
Transactions value $: -$35,081
Form type: 4
Date filed: 6/7/2021, 08:23 PM
Previous filing: Jun 3, 2021
Next filing: Sep 3, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCAT	Common Stock	Sale	-$35.1K	-665	-3.93%	$52.75	16.3K	Jun 3, 2021	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December, 15 2020, in accordance with Rule 10b5-1.
F2	Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $52.51 to $52.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.

Content

The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on December, 15 2020, in accordance with Rule 10b5-1.

Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $52.51 to $52.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote.